{"DataElement":{"publicId":"6586584","version":"1","preferredName":"Iris Uveal Melanoma AJCC Edition 8 Clinical Distant Metastasis M Category","preferredDefinition":"Extent of the distant metastasis for iris melanoma based on information obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter), using AJCC Ed. 8 criteria.","longName":"IRIS_AJC8_CLN_M_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6584938","version":"1","preferredName":"Iris Uveal Melanoma Clinical M Category","preferredDefinition":"The colored disc of the eye composed of connective tissue, epithelium, and endothelium. It separates the anterior chamber from the posterior chamber._A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._One criteria of the TNM staging system. M refers to the presence of metastasis.","longName":"6584932v1.0:2207806v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6584932","version":"1","preferredName":"Iris Uveal Melanoma","preferredDefinition":"The colored disc of the eye composed of connective tissue, epithelium, and endothelium. It separates the anterior chamber from the posterior chamber.:A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B.","longName":"C12737:C7712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Iris","conceptCode":"C12737","definition":"The colored disc of the eye composed of connective tissue, epithelium, and endothelium. It separates the anterior chamber from the posterior chamber.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Uveal Melanoma","conceptCode":"C7712","definition":"A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CB01ACC-61E5-4C0A-E053-F662850AF5D4","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"ONEDATA","dateModified":"2018-12-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207806","version":"1","preferredName":"Clinical M Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  M refers to the presence of metastasis.","longName":"C25398:C25727","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-30E1-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7CB02A7D-FCFE-4C84-E053-F662850A17A3","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"TAYLORT","dateModified":"2019-09-06","changeDescription":"9-6-19 TMT released per MC.; 12/10/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6586487","version":"1","preferredName":"Uveal Melanoma American Joint Committee on Cancer Edition 8 Clinical M Category","preferredDefinition":"A clinical finding about one or more characteristics of uveal melanoma, following the rules of the TNM AJCC v8 classification system as they pertain to distant metastases._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. M refers to the presence of metastasis._A grouping of items based on some commonality or by user defined characteristics.","longName":"6586487v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"3","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"pM1","valueDescription":"Uveal Melanoma pM1 TNM Finding v8","ValueMeaning":{"publicId":"6586489","version":"1","preferredName":"Uveal Melanoma pM1 TNM Finding v8","longName":"6586489","preferredDefinition":"Uveal melanoma with distant metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uveal Melanoma pM1 TNM Finding v8","conceptCode":"C140613","definition":"Uveal melanoma with distant metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CB2C579-9518-05B0-E053-F662850A757D","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"ONEDATA","dateModified":"2018-12-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CB2C579-9531-05B0-E053-F662850A757D","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"ONEDATA","dateModified":"2018-12-10","deletedIndicator":"No"},{"value":"cM1c","valueDescription":"Uveal Melanoma cM1c TNM Finding v8","ValueMeaning":{"publicId":"6586491","version":"1","preferredName":"Uveal Melanoma cM1c TNM Finding v8","longName":"6586491","preferredDefinition":"Uveal melanoma with largest diameter of the largest metastasis 8.1 cm or more. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uveal Melanoma cM1c TNM Finding v8","conceptCode":"C140610","definition":"Uveal melanoma with largest diameter of the largest metastasis 8.1 cm or more. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CB2C579-953E-05B0-E053-F662850A757D","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"ONEDATA","dateModified":"2018-12-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CB2C579-9557-05B0-E053-F662850A757D","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"ONEDATA","dateModified":"2018-12-10","deletedIndicator":"No"},{"value":"cM1b","valueDescription":"Uveal Melanoma cM1b TNM Finding v8","ValueMeaning":{"publicId":"6586493","version":"1","preferredName":"Uveal Melanoma cM1b TNM Finding v8","longName":"6586493","preferredDefinition":"Uveal melanoma with largest diameter of the largest metastasis 3.1-8.0 cm. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uveal Melanoma cM1b TNM Finding v8","conceptCode":"C140609","definition":"Uveal melanoma with largest diameter of the largest metastasis 3.1-8.0 cm. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CB2C579-9564-05B0-E053-F662850A757D","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"ONEDATA","dateModified":"2018-12-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CB2C579-957D-05B0-E053-F662850A757D","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"ONEDATA","dateModified":"2018-12-10","deletedIndicator":"No"},{"value":"cM1a","valueDescription":"Uveal Melanoma cM1a TNM Finding v8","ValueMeaning":{"publicId":"6586495","version":"1","preferredName":"Uveal Melanoma cM1a TNM Finding v8","longName":"6586495","preferredDefinition":"Uveal melanoma with largest diameter of the largest metastasis 3.0 cm or less. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uveal Melanoma cM1a TNM Finding v8","conceptCode":"C140608","definition":"Uveal melanoma with largest diameter of the largest metastasis 3.0 cm or less. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CB2C579-958A-05B0-E053-F662850A757D","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"ONEDATA","dateModified":"2018-12-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CB2C579-95A3-05B0-E053-F662850A757D","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"ONEDATA","dateModified":"2018-12-10","deletedIndicator":"No"},{"value":"cM1","valueDescription":"Uveal Melanoma cM1 TNM Finding v8","ValueMeaning":{"publicId":"6586497","version":"1","preferredName":"Uveal Melanoma cM1 TNM Finding v8","longName":"6586497","preferredDefinition":"Uveal melanoma with distant metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uveal Melanoma cM1 TNM Finding v8","conceptCode":"C140607","definition":"Uveal melanoma with distant metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CB2C579-95B0-05B0-E053-F662850A757D","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"ONEDATA","dateModified":"2018-12-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CB2C579-95C9-05B0-E053-F662850A757D","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"ONEDATA","dateModified":"2018-12-10","deletedIndicator":"No"},{"value":"cM0","valueDescription":"Uveal Melanoma cM0 TNM Finding v8","ValueMeaning":{"publicId":"6586499","version":"1","preferredName":"Uveal Melanoma cM0 TNM Finding v8","longName":"6586499","preferredDefinition":"Uveal melanoma with no distant metastasis by clinical classification. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uveal Melanoma cM0 TNM Finding v8","conceptCode":"C140606","definition":"Uveal melanoma with no distant metastasis by clinical classification. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CB2C579-95D6-05B0-E053-F662850A757D","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"ONEDATA","dateModified":"2018-12-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CB2C579-95EF-05B0-E053-F662850A757D","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"ONEDATA","dateModified":"2018-12-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6586502","version":"1","preferredName":"Uveal Melanoma Clinical Distant Metastasis TNM Finding v8 American Joint Committee on Cancer M Category Category","preferredDefinition":"A clinical finding about one or more characteristics of uveal melanoma, following the rules of the TNM AJCC v8 classification system as they pertain to distant metastases.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. M refers to the presence of metastasis.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C140605:C39315:C25727:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uveal Melanoma Clinical Distant Metastasis TNM Finding v8","conceptCode":"C140605","definition":"A clinical finding about one or more characteristics of uveal melanoma, following the rules of the TNM AJCC v8 classification system as they pertain to distant metastases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CBF1426-B615-0B83-E053-F662850A829A","latestVersionIndicator":"Yes","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"ONEDATA","dateModified":"2018-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7CB2C579-94FC-05B0-E053-F662850A757D","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"TAYLORT","dateModified":"2019-09-06","changeDescription":"9-6-19 TMT released per MC.; 12/10/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"6581919","version":"1","longName":"Uveal","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Clinical M category","type":"Preferred Question Text","description":"Clinical M category","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7CC04F59-1A90-7DCF-E053-F662850A1A40","latestVersionIndicator":"Yes","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"TAYLORT","dateModified":"2019-09-06","changeDescription":"9-6-19 TMT released per MC.; 12/11/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}